Sian Bigora Processa Pharmaceuticals, Inc. (PCSA) insider trading activity

Sian Bigora is Chief Development Officer of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 21,878 shares of PCSA, which is worth approximately $18,596. The most recent transaction as insider was on Jul 10, 2024, when has been sold 225 shares (Common Stock) at a price of $1.71 per share, resulting in proceeds of $384. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.9K

0% 3M change

94.57% 12M change

Total Value Held $18,596

Sian Bigora Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 10 2024	SELL Payment of exercise price or tax liability	$384 $1.71 p/Share	225 Reduced 1.02%	21,878 Common Stock
Jul 10 2024	BUY Exercise of conversion of derivative security	-	644 Added 2.83%	22,103 Common Stock
Apr 05 2024	SELL Payment of exercise price or tax liability	$1,026 $2.79 p/Share	368 Reduced 1.69%	21,459 Common Stock
Apr 05 2024	BUY Exercise of conversion of derivative security	-	1,675 Added 7.13%	21,827 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$1,026 $2.79 p/Share	368 Reduced 1.69%	21,458 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	1,675 Added 7.13%	21,826 Common Stock
Aug 05 2022	BUY Exercise of conversion of derivative security	-	7,601 Added 1.85%	403,019 Common Stock
Aug 05 2021	BUY Grant, award, or other acquisition	-	7,601 Added 1.89%	395,418 Common Stock

Sian Bigora

Chief Development Officer

Hanover, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Value

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Processa Pharmaceuticals, Inc.

Track Activities on PCSA

Account